Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Surgery Partners (SGRY) Revenue (2016 - 2025)

Historic Revenue for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $821.5 million.

  • Surgery Partners' Revenue rose 663.29% to $821.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 billion, marking a year-over-year increase of 1014.3%. This contributed to the annual value of $3.1 billion for FY2024, which is 1352.39% up from last year.
  • Latest data reveals that Surgery Partners reported Revenue of $821.5 million as of Q3 2025, which was up 663.29% from $826.2 million recorded in Q2 2025.
  • In the past 5 years, Surgery Partners' Revenue registered a high of $864.4 million during Q4 2024, and its lowest value of $512.4 million during Q1 2021.
  • Moreover, its 5-year median value for Revenue was $674.1 million (2023), whereas its average is $686.6 million.
  • As far as peak fluctuations go, Surgery Partners' Revenue soared by 4499.6% in 2021, and later skyrocketed by 400.23% in 2023.
  • Surgery Partners' Revenue (Quarter) stood at $610.2 million in 2021, then rose by 15.88% to $707.1 million in 2022, then rose by 4.0% to $735.4 million in 2023, then grew by 17.54% to $864.4 million in 2024, then fell by 4.96% to $821.5 million in 2025.
  • Its last three reported values are $821.5 million in Q3 2025, $826.2 million for Q2 2025, and $776.0 million during Q1 2025.